1 / 2

Explore the Major Pharmaceutical Research and Development Spenders

During the COVID19 pandemic, the global pharma sectoru2019s R&D skills were pushed into the limelight as the world was desperate for a lifeline. Now, as the pandemic begins to loosen its grip, the sector continues to make aggressive investments in Research and Development (R&D), ensuring future innovations and breakthroughs in healthcare.

Insights10
Download Presentation

Explore the Major Pharmaceutical Research and Development Spenders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TOP 20 2023 Revenue ($Bn) 2023 PHARMA COMPANIES R&D Spend ($Bn) BY R&D SPENDS (2023) 60.1 30.5 49.6 14.7 45.44 13.7 54.8 12.0 45.8 10.9 58.5 10.7 34.1 9.3 45.0 9.3 37.7 7.7 54.3 7.7

  2. 50.2 7.3 27.8 6.3 27.3 5.7 19.3 4.8 28.7 4.8 28.2 4.8 33.7 4.7 13.1 4.4 9.9 3.2 9.8 2.5 Source: Annual Reports 2023

More Related